Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $171B |
| FY2017, ended Dec 30, 2017 | $215B |
| FY2018, ended Dec 29, 2018 | $210B |
| FY2019, ended Dec 28, 2019 | $257B |
| FY2020, ended Dec 26, 2020 | $191B |
| FY2021, ended Dec 25, 2021 | $209B |
| FY2022, ended Dec 31, 2022 | $109B |
| FY2023, ended Dec 30, 2023 | $212B |
| FY2024, ended Dec 28, 2024 | $87.9B |
| FY2025, ended Dec 27, 2025 | $181B |
| Trailing 12 months to Jun 27, 2026 (through Q2 FY2026) | $647B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $59.4B |
| FY2017, ended Dec 30, 2017 | $62.8B |
| FY2018, ended Dec 29, 2018 | $70.8B |
| FY2019, ended Dec 28, 2019 | $72.0B |
| FY2020, ended Dec 26, 2020 | $77.9B |
| FY2021, ended Dec 25, 2021 | $79.0B |
| FY2022, ended Dec 31, 2022 | $63.1B |
| FY2023, ended Dec 30, 2023 | $54.2B |
| FY2024, ended Dec 28, 2024 | $53.1B |
| FY2025, ended Dec 27, 2025 | $52.9B |
| Trailing 12 months to Jun 27, 2026 (through Q2 FY2026) | $57.0B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $10.3B | $12.2B |
| FY2017, ended Dec 30, 2017 | $9.60B | $10.3B |
| FY2018, ended Dec 29, 2018 | $21.1B | $14.3B |
| FY2019, ended Dec 28, 2019 | $21.0B | $16.9B |
| FY2020, ended Dec 26, 2020 | $20.9B | $21.6B |
| FY2021, ended Dec 25, 2021 | $19.9B | $10.7B |
| FY2022, ended Dec 31, 2022 | $8.01B | −$9.41B |
| FY2023, ended Dec 30, 2023 | $1.69B | −$14.3B |
| FY2024, ended Dec 28, 2024 | −$18.8B | −$15.7B |
| FY2025, ended Dec 27, 2025 | −$267M | −$4.95B |
| Trailing 12 months to Jun 27, 2026 (through Q2 FY2026) | −$11.3B | $2.83B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $5.56B |
| FY2017, ended Dec 30, 2017 | $3.43B |
| FY2018, ended Dec 29, 2018 | $3.02B |
| FY2019, ended Dec 28, 2019 | $4.19B |
| FY2020, ended Dec 26, 2020 | $5.87B |
| FY2021, ended Dec 25, 2021 | $4.83B |
| FY2022, ended Dec 31, 2022 | $11.1B |
| FY2023, ended Dec 30, 2023 | $7.08B |
| FY2024, ended Dec 28, 2024 | $8.25B |
| FY2025, ended Dec 27, 2025 | $14.3B |
| Trailing 12 months to Jun 27, 2026 (through Q2 FY2026) | $12.9B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $29.9B |
| FY2017, ended Dec 30, 2017 | $26.8B |
| FY2018, ended Dec 29, 2018 | $26.4B |
| FY2019, ended Dec 28, 2019 | $29.0B |
| FY2020, ended Dec 26, 2020 | $36.4B |
| FY2021, ended Dec 25, 2021 | $38.1B |
| FY2022, ended Dec 31, 2022 | $42.0B |
| FY2023, ended Dec 30, 2023 | $49.3B |
| FY2024, ended Dec 28, 2024 | $50.0B |
| FY2025, ended Dec 27, 2025 | $46.6B |
| Trailing 12 months to Jun 27, 2026 (through Q2 FY2026) | $50.5B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 6.7% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 4.73B |
| FY2017, ended Dec 30, 2017 | 4.67B |
| FY2018, ended Dec 29, 2018 | 4.50B |
| FY2019, ended Dec 28, 2019 | 4.28B |
| FY2020, ended Dec 26, 2020 | 4.06B |
| FY2021, ended Dec 25, 2021 | 4.07B |
| FY2022, ended Dec 31, 2022 | 4.14B |
| FY2023, ended Dec 30, 2023 | 4.23B |
| FY2024, ended Dec 28, 2024 | 4.33B |
| FY2025, ended Dec 27, 2025 | 5.00B |
| Trailing 12 months to Jun 27, 2026 (through Q2 FY2026) | 5.04B |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $2.59B | $1.44B |
| FY2017, ended Dec 30, 2017 | $3.62B | $1.36B |
| FY2018, ended Dec 29, 2018 | $10.7B | $1.55B |
| FY2019, ended Dec 28, 2019 | $13.6B | $1.71B |
| FY2020, ended Dec 26, 2020 | $14.2B | $1.85B |
| FY2021, ended Dec 25, 2021 | $2.42B | $2.04B |
| FY2022, ended Dec 31, 2022 | $0 | $3.13B |
| FY2023, ended Dec 30, 2023 | $0 | $3.23B |
| FY2024, ended Dec 28, 2024 | — | $3.41B |
| FY2025, ended Dec 27, 2025 | — | $2.43B |
| Trailing 12 months to Jun 27, 2026 (through Q2 FY2026) | — | $2.39B |
Valuation
At current price- Market Cap
- $473B
- P/E
- n/m. Market cap / net income (TTM)
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 8.3×
- Price / Book
- 5.4×
- EV / EBITDA
- 41.5×
Growth
Trailing 12 months- Revenue (TTM)
- $57.0B
- Revenue Growth YoY
- 7.5%
- Revenue CAGR 3Y
- −5.7%
- Revenue CAGR 5Y
- −7.5%
- EPS Growth YoY
- n/m. Diluted EPS, TTM vs. TTM a year earlier
- Net Income Growth YoY
- n/m. TTM vs. TTM a year earlier
Profitability
Trailing 12 months- Gross Margin
- 38.6%
- Operating Margin
- −0.1%
- Net Margin
- −19.8%
- FCF Margin
- 5.0%
- Return on Equity
- −12.2%
Earnings
Trailing 12 months- Net Income
- −$11.3B
- EPS (diluted)
- −$2.09
- EBITDA
- $12.3B
- Operating Income
- −$77.0M
Balance Sheet
As of Jun 27, 2026- Cash and cash equivalents
- $12.9B
- Total Debt
- $50.5B
- Net Debt
- $37.7B
- Total Assets
- $202B
- Total Liabilities
- $99.3B
- Shareholders' Equity
- $87.5B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $14.9B
- Capital Expenditure
- $12.1B
- Free Cash Flow
- $2.83B
Dividends and risk
Last 12 months- Dividend Yield
- 0.0%
- Dividend / Share
- $0.00
- Beta (5Y)
- 2.22
Every ratio is calculated from the company’s reported figures.